|
|
|
|
LEADER |
01386nam a2200301 u 4500 |
001 |
10009847 |
003 |
upatras |
005 |
20210303084156.0 |
008 |
881025m19921993us eng |
040 |
|
|
|a GR-PaULI
|c GR-PaULI
|
041 |
0 |
|
|a eng
|
082 |
0 |
4 |
|a 615.19
|
245 |
1 |
0 |
|a Pharmaceutical dosage forms
|b parenteral medications
|
250 |
|
|
|a 2nd ed. rev. and expanded
|
260 |
|
|
|a New York
|b Marcel Dekker
|c 1992-1993
|
300 |
|
|
|a 3 v.
|b fig.
|c 25 cm.
|
650 |
|
4 |
|a Φάρμακα
|x Χορήγηση
|9 1266
|
650 |
|
4 |
|a Φαρμακευτική τεχνολογία
|9 36666
|
650 |
|
4 |
|a Φαρμακολογία
|x Δοσολογία
|9 36677
|
700 |
1 |
|
|a Avis, Kenneth E.
|d 1918-
|4 edt
|9 125409
|
700 |
1 |
|
|a Lieberman, Herbert A.
|d 1920-
|4 edt
|9 125410
|
700 |
1 |
|
|a Lachman, Leon
|d 1929-
|4 edt
|9 110826
|
852 |
|
|
|a GR-PaULI
|b ΠΑΤΡΑ
|b ΒΚΠ
|b ΒΣ1
|k ΑΣΧΞ
|h 615.19 PHA
|m 25319
|p 025000233486
|t 1
|3 v.3
|
852 |
|
|
|a GR-PaULI
|b ΠΑΤΡΑ
|b ΒΚΠ
|b ΒΣ1
|k ΑΣΧΞ
|h 615.19 PHA
|m 25322
|p 025000233485
|t 2
|3 v.3
|
942 |
|
|
|2 ddc
|c BK15
|
952 |
|
|
|0 0
|1 0
|3 v.3
|4 0
|6 615_190000000000000_PHA
|7 0
|9 138776
|a LISP
|b LISP
|c BSC
|d 2016-04-24
|i 25319
|l 0
|o 615.19 PHA
|p 025000233486
|r 2016-04-24 00:00:00
|t 1
|w 2016-04-24
|y BK15
|
952 |
|
|
|0 0
|1 0
|2 ddc
|3 v.3
|4 0
|6 615_190000000000000_PHA
|7 0
|9 138777
|a LISP
|b LISP
|c ALFb
|d 2016-04-24
|i 25322
|l 0
|o 615.19 PHA
|p 025000233485
|r 2016-04-24 00:00:00
|t 2
|w 2016-04-24
|y BK15
|
999 |
|
|
|c 90771
|d 90771
|